#United States #Louisville #GammaTile #GT Medical #UofL Health

GT Medical Technologies Welcomes UofL Health as GammaTile® Center of Excellence

On July 24, 2025, GT Medical Technologies proudly announced that UofL Health has been designated as the latest GammaTile® Center of Excellence. This recognition underscores the institution's exceptional commitment to the treatment of brain tumors and the advancement of patient care. The GammaTile® technology is utilized in both the Brown Cancer Center and UofL Hospital located in Louisville, Kentucky.

GT Medical Technologies, a pioneer in medical devices focused on improving outcomes for brain tumor patients, emphasizes the importance of this designation. The GammaTile procedure represents a significant step forward in the treatment of brain tumors, providing immediate targeted radiation therapy at the tumor site immediately following surgical removal. This innovative approach addresses a critical gap present in traditional methods, where patients often endure waiting periods between surgery and radiation therapy to allow for proper healing.

Dr. Brian Williams, Director of Brain Tumor and Skull Base Program at UofL Health, expressed his enthusiasm about the recognition. He stated, "UofL Health and the Department of Neurosurgery at UofL are committed to transforming patients' lives through compassionate patient-centered care, innovative research, and education. Recognition as one of the first GammaTile Centers of Excellence in Kentucky reflects our commitment to the community to bring world-class care to the commonwealth."

The designation of GammaTile Center of Excellence is not granted lightly. It is awarded to institutions that excel in the GammaTile procedure, showcasing their expertise by meeting rigorous clinical criteria, achieving annual case minimums, and fulfilling ongoing educational commitments. Among the distinguished physicians from UofL Health now recognized under this program are:

• - Adrianna Masters, MD, PhD - Radiation Oncologist
• - Akshitkumar Mistry, MD - Neurosurgeon
• - Brian Williams, MD - Neurosurgeon
• - Keith Sowards, MS - Medical Physicist

Understanding GammaTile®

GammaTile is a revolutionary treatment method for patients with operable brain tumors. It consists of a bioabsorbable collagen implant embedded with radiation seeds, which enables the delivery of targeted radiation therapy directly from within the surgical cavity at the time of tumor removal. This innovation ensures that radiation is directed towards the remaining cancer cells when they are at their lowest levels post-surgery, thereby minimizing the chances of regrowth while sparing surrounding healthy brain tissue from unnecessary radiation exposure.

Since its introduction to the U.S. market in March 2020, GammaTile has been embraced by over 100 leading medical centers, marking its growing acceptance in both community and academic healthcare environments. The FDA clearance it received showcases its effectiveness and safety, setting a new standard for brain tumor management.

GT Medical Technologies was founded by a team of dedicated brain tumor specialists. They have recognized the pressing needs in the realm of brain tumor treatment and are passionately committed to enhancing the quality of life for patients through their innovative solutions. The company is dedicated not only to improving clinical outcomes but also to ensuring that patients have access to cutting-edge treatment options that elevate the standard of care.

For more information regarding the GammaTile® procedure, visit gammatile.com and follow them on social media platforms like Facebook, Instagram, LinkedIn, and X.

In conclusion, the designation of UofL Health as a GammaTile Center of Excellence is a significant milestone for both the institution and the patients it serves, reflecting a commitment to pioneering care methods and advancing the field of oncology.